1	rail_id
2	external_id
3	study
4	tcga_barcode
5	gdc_file_id
6	gdc_cases.project.name
7	gdc_cases.project.released
8	gdc_cases.project.state
9	gdc_cases.project.primary_site
10	gdc_cases.project.project_id
11	cgc_sample_sample_type
12	gdc_cases.case_id
13	gdc_updated_datetime
14	gdc_file_name
15	gdc_submitter_id
16	gdc_file_size
17	gdc_access
18	gdc_platform
19	gdc_state
20	gdc_type
21	gdc_file_state
22	gdc_experimental_strategy
23	gdc_data_type
24	gdc_md5sum
25	gdc_data_format
26	gdc_data_category
27	gdc_center.code
28	gdc_center.name
29	gdc_center.short_name
30	gdc_center.center_id
31	gdc_center.namespace
32	gdc_center.center_type
33	gdc_metadata_files.updated_datetime.analysis
34	gdc_metadata_files.created_datetime.analysis
35	gdc_metadata_files.file_name.analysis
36	gdc_metadata_files.md5sum.analysis
37	gdc_metadata_files.data_format.analysis
38	gdc_metadata_files.access.analysis
39	gdc_metadata_files.file_id.analysis
40	gdc_metadata_files.data_category.analysis
41	gdc_metadata_files.file_size.analysis
42	gdc_metadata_files.file_state.analysis
43	gdc_metadata_files.updated_datetime.experiment
44	gdc_metadata_files.file_name.experiment
45	gdc_metadata_files.md5sum.experiment
46	gdc_metadata_files.file_id.experiment
47	gdc_metadata_files.file_size.experiment
48	gdc_metadata_files.updated_datetime.run
49	gdc_metadata_files.file_name.run
50	gdc_metadata_files.md5sum.run
51	gdc_metadata_files.file_id.run
52	gdc_metadata_files.file_size.run
53	gdc_cases.updated_datetime
54	gdc_cases.submitter_id
55	gdc_cases.demographic.updated_datetime
56	gdc_cases.demographic.gender
57	gdc_cases.demographic.submitter_id
58	gdc_cases.demographic.year_of_birth
59	gdc_cases.demographic.race
60	gdc_cases.demographic.demographic_id
61	gdc_cases.demographic.ethnicity
62	gdc_cases.demographic.year_of_death
63	gdc_cases.project.program.dbgap_accession_number
64	gdc_cases.project.program.name
65	gdc_cases.project.program.program_id
66	gdc_cases.tissue_source_site.project
67	gdc_cases.tissue_source_site.bcr_id
68	gdc_cases.tissue_source_site.code
69	gdc_cases.tissue_source_site.tissue_source_site_id
70	gdc_cases.tissue_source_site.name
71	gdc_cases.diagnoses.classification_of_tumor
72	gdc_cases.diagnoses.primary_diagnosis
73	gdc_cases.diagnoses.submitter_id
74	gdc_cases.diagnoses.tumor_stage
75	gdc_cases.diagnoses.age_at_diagnosis
76	gdc_cases.diagnoses.vital_status
77	gdc_cases.diagnoses.morphology
78	gdc_cases.diagnoses.days_to_death
79	gdc_cases.diagnoses.days_to_last_follow_up
80	gdc_cases.diagnoses.diagnosis_id
81	gdc_cases.diagnoses.tissue_or_organ_of_origin
82	gdc_cases.diagnoses.days_to_birth
83	gdc_cases.diagnoses.treatments.submitter_id
84	gdc_cases.diagnoses.treatments.treatment_id
85	gdc_cases.samples.sample_type_id
86	gdc_cases.samples.oct_embedded
87	gdc_cases.samples.submitter_id
88	gdc_cases.samples.intermediate_dimension
89	gdc_cases.samples.sample_id
90	gdc_cases.samples.is_ffpe
91	gdc_cases.samples.pathology_report_uuid
92	gdc_cases.samples.sample_type
93	gdc_cases.samples.shortest_dimension
94	gdc_cases.samples.days_to_collection
95	gdc_cases.samples.initial_weight
96	gdc_cases.samples.longest_dimension
97	gdc_cases.samples.portions.creation_datetime
98	gdc_cases.samples.portions.portion_number
99	gdc_cases.samples.portions.weight
100	gdc_cases.samples.portions.submitter_id
101	gdc_cases.samples.portions.portion_id
102	gdc_cases.samples.portions.analytes.analyte_type
103	gdc_cases.samples.portions.analytes.submitter_id
104	gdc_cases.samples.portions.analytes.analyte_id
105	gdc_cases.samples.portions.analytes.a260_a280_ratio
106	gdc_cases.samples.portions.analytes.concentration
107	gdc_cases.samples.portions.analytes.spectrophotometer_method
108	gdc_cases.samples.portions.analytes.analyte_type_id
109	gdc_cases.samples.portions.analytes.aliquots.source_center
110	gdc_cases.samples.portions.analytes.aliquots.submitter_id
111	gdc_cases.samples.portions.analytes.aliquots.aliquot_id
112	gdc_cases.samples.portions.analytes.aliquots.concentration
113	gdc_cases.samples.portions.annotations.category
114	gdc_cases.samples.portions.annotations.status
115	gdc_cases.samples.portions.annotations.classification
116	gdc_cases.samples.portions.annotations.updated_datetime
117	gdc_cases.samples.portions.annotations.created_datetime
118	gdc_cases.samples.portions.annotations.notes
119	gdc_cases.samples.portions.annotations.submitter_id
120	gdc_cases.samples.portions.annotations.annotation_id
121	gdc_cases.samples.annotations.category
122	gdc_cases.samples.annotations.status
123	gdc_cases.samples.annotations.classification
124	gdc_cases.samples.annotations.updated_datetime
125	gdc_cases.samples.annotations.created_datetime
126	gdc_cases.samples.annotations.notes
127	gdc_cases.samples.annotations.submitter_id
128	gdc_cases.samples.annotations.annotation_id
129	gdc_cases.exposures.cigarettes_per_day
130	gdc_cases.exposures.weight
131	gdc_cases.exposures.alcohol_history
132	gdc_cases.exposures.bmi
133	gdc_cases.exposures.years_smoked
134	gdc_cases.exposures.height
135	gdc_cases.exposures.exposure_id
136	gdc_cases.exposures.submitter_id
137	gdc_associated_entities.entity_type
138	cgc_filename
139	cgc_file_upload_date
140	cgc_file_last_modified_date
141	cgc_file_submitter_id
142	cgc_file_sample
143	cgc_file_data_subtype
144	cgc_file_size
145	cgc_file_access_level
146	cgc_file_platform
147	cgc_file_investigation
148	cgc_file_experimental_strategy
149	cgc_file_data_type
150	cgc_file_aliquot
151	cgc_file_data_submitting_center
152	cgc_file_file_id
153	cgc_file_case
154	cgc_file_disease_type
155	cgc_file_data_format
156	cgc_file_portion
157	cgc_file_published_date
158	cgc_file_analyte
159	cgc_sample_country_of_sample_procurement
160	cgc_sample_is_ffpe
161	cgc_sample_sample_type_code
162	cgc_sample_shortest_dimension
163	cgc_sample_tissue_source_site
164	cgc_sample_days_to_collection
165	cgc_sample_portion
166	cgc_sample_intermediate_dimension
167	cgc_sample_tissue_source_site_code
168	cgc_sample_file
169	cgc_sample_initial_weight
170	cgc_sample_id
171	cgc_sample_longest_dimension
172	cgc_case_drug_therapy
173	cgc_case_program
174	cgc_case_year_of_diagnosis
175	cgc_case_new_tumor_event
176	cgc_case_primary_therapy_outcome_success
177	cgc_case_tumor_status
178	cgc_case_sample
179	cgc_case_age_at_diagnosis
180	cgc_case_file
181	cgc_case_vital_status
182	cgc_case_days_to_death
183	cgc_case_id
184	cgc_case_ethnicity
185	cgc_case_follow_up
186	cgc_case_new_tumor_event_after_initial_treatment
187	cgc_case_days_to_last_follow_up
188	cgc_case_prior_diagnosis
189	cgc_case_primary_site
190	cgc_case_icd_o3site
191	cgc_case_pathologic_n
192	cgc_case_histological_diagnosis
193	cgc_case_performance_status_score_ecog
194	cgc_case_performance_status_score_timing
195	cgc_case_clinical_stage
196	cgc_case_pathologic_stage
197	cgc_case_performance_status_score_karnofsky
198	cgc_case_pathologic_t
199	cgc_case_icd_o3histology
200	cgc_case_other_histological_diagnosis
201	cgc_case_gender
202	cgc_case_icd10
203	cgc_case_batch_number
204	cgc_case_clinical_m
205	cgc_case_clinical_n
206	cgc_case_radiation_therapy
207	cgc_case_race
208	cgc_case_clinical_t
209	cgc_portion_portion_number
210	cgc_portion_weight
211	cgc_portion_slide
212	cgc_portion_analyte
213	cgc_portion_file
214	cgc_portion_id
215	cgc_slide_percent_tumor_nuclei
216	cgc_slide_percent_normal_cells
217	cgc_slide_percent_monocyte_infiltration
218	cgc_slide_percent_lymphocyte_infiltration
219	cgc_slide_percent_stromal_cells
220	cgc_slide_section_location
221	cgc_slide_percent_necrosis
222	cgc_slide_percent_neutrophil_infiltration
223	cgc_slide_id
224	cgc_slide_percent_tumor_cells
225	cgc_drug_therapy_drug_name
226	cgc_drug_therapy_pharmaceutical_therapy_type
227	cgc_drug_therapy_id
228	cgc_radiation_therapy_id
229	cgc_radiation_therapy_radiation_type
230	cgc_radiation_therapy_radiation_therapy_site
231	cgc_follow_up_new_tumor_event
232	cgc_follow_up_new_tumor_event_after_initial_treatment
233	cgc_follow_up_days_to_last_follow_up
234	cgc_follow_up_tumor_status
235	cgc_follow_up_vital_status
236	cgc_follow_up_days_to_death
237	cgc_follow_up_id
238	xml_bcr_patient_barcode
239	xml_additional_studies
240	xml_tissue_source_site
241	xml_patient_id
242	xml_informed_consent_verified
243	xml_icd_o_3_site
244	xml_icd_o_3_histology
245	xml_icd_10
246	xml_tissue_prospective_collection_indicator
247	xml_tissue_retrospective_collection_indicator
248	xml_days_to_birth
249	xml_race_list
250	xml_ethnicity
251	xml_other_dx
252	xml_history_of_neoadjuvant_treatment
253	xml_vital_status
254	xml_days_to_last_followup
255	xml_days_to_death
256	xml_radiation_therapy
257	xml_postoperative_rx_tx
258	xml_person_neoplasm_cancer_status
259	xml_has_new_tumor_events_information
260	xml_day_of_form_completion
261	xml_month_of_form_completion
262	xml_year_of_form_completion
263	xml_has_follow_ups_information
264	xml_has_drugs_information
265	xml_has_radiations_information
266	xml_primary_pathology_histological_type
267	xml_primary_pathology_leiomyosarcoma_histologic_subtype
268	xml_primary_pathology_primary_tumor_lower_uterus_segment
269	xml_primary_pathology_leiomyosarcoma_major_vessel_involvement
270	xml_primary_pathology_synovial_sarcoma
271	xml_primary_pathology_tumor_depth
272	xml_primary_pathology_tumor_tissue_sites
273	xml_primary_pathology_tumor_tissue_site_other
274	xml_primary_pathology_days_to_initial_pathologic_diagnosis
275	xml_primary_pathology_age_at_initial_pathologic_diagnosis
276	xml_primary_pathology_year_of_initial_pathologic_diagnosis
277	xml_primary_pathology_margin_status
278	xml_primary_pathology_residual_tumor
279	xml_primary_pathology_tumor_total_necrosis_percent
280	xml_primary_pathology_tumor_necrosis_percent
281	xml_primary_pathology_mitotic_count
282	xml_primary_pathology_tumor_multifocal
283	xml_primary_pathology_discontiguous_lesion_count
284	xml_primary_pathology_tumor_sizes
285	xml_primary_pathology_radiologic_tumor_burden
286	xml_primary_pathology_pathologic_tumor_burden
287	xml_primary_pathology_local_disease_recurrence
288	xml_primary_pathology_metastatic_diagnosis
289	xml_primary_pathology_metastatic_site_at_diagnosis
290	xml_primary_pathology_metastatic_site_at_diagnosis_other
291	xml_primary_pathology_contiguous_organ_resection_site
292	xml_primary_pathology_other_contiguous_organ_resection_site
293	xml_primary_pathology_contiguous_organ_invaded
294	xml_primary_pathology_well_differentiated_liposarcoma_primary_dx
295	xml_primary_pathology_days_to_well_differentiated_liposarcoma_primary_dx
296	xml_primary_pathology_days_to_well_differentiated_liposarcoma_resection
297	xml_tumor_tissue_site
298	xml_adenocarcinoma_invasion
299	xml_histological_type
300	xml_histological_type_other
301	xml_tumor_type
302	xml_anatomic_neoplasm_subdivision
303	xml_anatomic_neoplasm_subdivision_other
304	xml_days_to_initial_pathologic_diagnosis
305	xml_age_at_initial_pathologic_diagnosis
306	xml_year_of_initial_pathologic_diagnosis
307	xml_initial_pathologic_diagnosis_method
308	xml_init_pathology_dx_method_other
309	xml_surgery_performed_type
310	xml_primary_lymph_node_presentation_assessment
311	xml_lymph_node_examined_count
312	xml_number_of_lymphnodes_positive_by_he
313	xml_number_of_lymphnodes_positive_by_ihc
314	xml_neoplasm_histologic_grade
315	xml_histologic_grading_tier_category
316	xml_maximum_tumor_dimension
317	xml_residual_tumor
318	xml_patient_death_reason
319	xml_source_of_patient_death_reason
320	xml_tobacco_smoking_history
321	xml_year_of_tobacco_smoking_onset
322	xml_stopped_smoking_year
323	xml_number_pack_years_smoked
324	xml_alcoholic_exposure_category
325	xml_frequency_of_alcohol_consumption
326	xml_amount_of_alcohol_consumption_per_day
327	xml_history_of_diabetes
328	xml_days_to_diabetes_onset
329	xml_history_of_chronic_pancreatitis
330	xml_days_to_pancreatitis_onset
331	xml_family_history_of_cancer
332	xml_relative_cancer_types
333	xml_targeted_molecular_therapy
334	xml_history_prior_surgery_type_other
335	xml_primary_therapy_outcome_success
336	xml_stage_event_system_version
337	xml_stage_event_clinical_stage
338	xml_stage_event_pathologic_stage
339	xml_stage_event_tnm_categories
340	xml_stage_event_psa
341	xml_stage_event_gleason_grading
342	xml_stage_event_ann_arbor
343	xml_stage_event_serum_markers
344	xml_stage_event_igcccg_stage
345	xml_stage_event_masaoka_stage
346	xml_days_to_last_known_alive
347	xml_preoperative_pretreatment_cea_level
348	xml_non_nodal_tumor_deposits
349	xml_circumferential_resection_margin
350	xml_venous_invasion
351	xml_lymphatic_invasion
352	xml_perineural_invasion_present
353	xml_microsatellite_instability
354	xml_number_of_loci_tested
355	xml_number_of_abnormal_loci
356	xml_kras_gene_analysis_performed
357	xml_kras_mutation_found
358	xml_kras_mutation_codon
359	xml_braf_gene_analysis_performed
360	xml_braf_gene_analysis_result
361	xml_synchronous_colon_cancer_present
362	xml_history_of_colon_polyps
363	xml_colon_polyps_present
364	xml_loss_expression_of_mismatch_repair_proteins_by_ihc
365	xml_loss_expression_of_mismatch_repair_proteins_by_ihc_results
366	xml_number_of_first_degree_relatives_with_cancer_diagnosis
367	xml_pleurodesis_performed
368	xml_pleurodesis_performed_90_days
369	xml_history_asbestos_exposure
370	xml_asbestos_exposure_type
371	xml_asbestos_exposure_source
372	xml_asbestos_exposure_age
373	xml_asbestos_exposure_years
374	xml_asbestos_exposure_age_last
375	xml_primary_occupation
376	xml_primary_occupation_other
377	xml_person_occupation_years_number
378	xml_blood_relative_cancer_history_list
379	xml_karnofsky_performance_score
380	xml_eastern_cancer_oncology_group
381	xml_performance_status_scale_timing
382	xml_primary_pathology_tumor_tissue_site
383	xml_primary_pathology_laterality
384	xml_primary_pathology_serum_mesothelin_prior_tx
385	xml_primary_pathology_serum_mesothelin_lower_limit
386	xml_primary_pathology_serum_mesothelin_upper_limit
387	xml_primary_pathology_creatinine_prior_tx
388	xml_primary_pathology_creatinine_norm_range_lower
389	xml_primary_pathology_creatinine_norm_range_upper
390	xml_primary_pathology_suv_of_pleura_max
391	xml_primary_pathology_mesothelioma_detection_method
392	xml_prior_glioma
393	xml_laterality
394	xml_lactate_dehydrogenase_result
395	xml_serum_calcium_result
396	xml_hemoglobin_result
397	xml_platelet_qualitative_result
398	xml_white_cell_count_result
399	xml_erythrocyte_sedimentation_rate_result
400	xml_number_of_lymphnodes_positive
401	xml_mitotane_therapy
402	xml_mitotane_therapy_adjuvant_setting
403	xml_therapeutic_mitotane_levels_achieved
404	xml_therapeutic_mitotane_lvl_recurrence
405	xml_mitotane_therapy_for_macroscopic_residual_disease
406	xml_therapeutic_mitotane_lvl_macroscopic_residual
407	xml_therapeutic_mitotane_lvl_progression
408	xml_post_surgical_procedure_assessment_thyroid_gland_carcinoma_status
409	xml_primary_pathology_ct_scan
410	xml_primary_pathology_ct_scan_findings
411	xml_primary_pathology_primary_lymph_node_presentation_assessment
412	xml_primary_pathology_lymph_node_examined_count
413	xml_primary_pathology_number_of_lymphnodes_positive_by_he
414	xml_primary_pathology_weiss_assessment_report
415	xml_primary_pathology_mitoses_count
416	xml_primary_pathology_metastatic_neoplasm_confirmed_diagnosis_method_names
417	xml_primary_pathology_metastatic_neoplasm_initial_diagnosis_anatomic_sites
418	xml_primary_pathology_excess_adrenal_hormone_history_types
419	xml_primary_pathology_germline_genotype_testing_report
420	xml_menopause_status
421	xml_birth_control_pill_history_usage_category
422	xml_number_of_successful_pregnancies_which_resulted_in_at_least_1_live_birth
423	xml_patient_pregnancy_spontaneous_abortion_count
424	xml_patient_pregnancy_therapeutic_abortion_count
425	xml_ectopic_pregnancy_count
426	xml_pregnancy_stillbirth_count
427	xml_female_breast_feeding_or_pregnancy_status_indicator
428	xml_total_number_of_pregnancies
429	xml_age_began_smoking_in_years
430	xml_patient_history_immune_system_and_related_disorders_names
431	xml_patient_history_immune_system_and_related_disorders_text
432	xml_assessment_timepoint_category
433	xml_days_to_performance_status_assessment
434	xml_tumor_response_cdus_type
435	xml_keratinizing_squamous_cell_carcinoma_present_indicator
436	xml_lymph_node_location_positive_pathology_names
437	xml_lymph_node_location_positive_pathology_text
438	xml_hysterectomy_performed_type
439	xml_hysterectomy_performed_text
440	xml_cervical_neoplasm_pathologic_margin_involved_type
441	xml_cervical_neoplasm_pathologic_margin_involved_text
442	xml_cervical_carcinoma_pelvic_extension_text
443	xml_lymphovascular_invasion_indicator
444	xml_cervical_carcinoma_corpus_uteri_involvement_indicator
445	xml_days_to_fdg_or_ct_pet_performed
446	xml_standardized_uptake_value_cervix_uteri_assessment_measurement
447	xml_fdg_or_ct_pet_performed_outcomes
448	xml_days_to_diagnostic_mri_performed
449	xml_diagnostic_mri_result_outcomes
450	xml_days_to_diagnostic_computed_tomography_performed
451	xml_diagnostic_ct_result_outcomes
452	xml_human_papillomavirus_types
453	xml_human_papillomavirus_other_type_text
454	xml_human_papillomavirus_laboratory_procedure_performed_name
455	xml_human_papillomavirus_laboratory_procedure_performed_text
456	xml_oligonucleotide_primer_pair_laboratory_procedure_performed_name
457	xml_pregnant_at_diagnosis
458	xml_treatment
459	xml_er_detection_method_text
460	xml_pgr_detection_method_text
461	xml_anatomic_neoplasm_subdivisions
462	xml_her2_neu_chromosone_17_signal_ratio_value
463	xml_axillary_lymph_node_stage_method_type
464	xml_axillary_lymph_node_stage_other_method_descriptive_text
465	xml_breast_carcinoma_surgical_procedure_name
466	xml_breast_neoplasm_other_surgical_procedure_descriptive_text
467	xml_breast_carcinoma_primary_surgical_procedure_name
468	xml_surgical_procedure_purpose_other_text
469	xml_breast_carcinoma_progesterone_receptor_status
470	xml_cytokeratin_immunohistochemistry_staining_method_micrometastasis_indicator
471	xml_breast_carcinoma_immunohistochemistry_er_pos_finding_scale
472	xml_immunohistochemistry_positive_cell_score
473	xml_her2_immunohistochemistry_level_result
474	xml_breast_cancer_surgery_margin_status
475	xml_margin_status
476	xml_lab_procedure_her2_neu_in_situ_hybrid_outcome_type
477	xml_breast_carcinoma_estrogen_receptor_status
478	xml_lab_proc_her2_neu_immunohistochemistry_receptor_status
479	xml_pos_finding_progesterone_receptor_other_measurement_scale_text
480	xml_positive_finding_estrogen_receptor_other_measurement_scale_text
481	xml_her2_erbb_pos_finding_cell_percent_category
482	xml_pos_finding_her2_erbb2_other_measurement_scale_text
483	xml_her2_erbb_method_calculation_method_text
484	xml_her2_neu_and_centromere_17_copy_number_analysis_input_total_number_count
485	xml_her2_and_centromere_17_positive_finding_other_measurement_scale_text
486	xml_her2_erbb_pos_finding_fluorescence_in_situ_hybridization_calculation_method_text
487	xml_fluorescence_in_situ_hybridization_diagnostic_procedure_chromosome_17_signal_result_range
488	xml_first_nonlymph_node_metastasis_anatomic_sites
489	xml_er_level_cell_percentage_category
490	xml_progesterone_receptor_level_cell_percent_category
491	xml_distant_metastasis_present_ind2
492	xml_metastatic_breast_carcinoma_estrogen_receptor_status
493	xml_metastatic_breast_carcinoma_estrogen_receptor_level_cell_percent_category
494	xml_metastatic_breast_carcinoma_immunohistochemistry_er_pos_cell_score
495	xml_metastatic_breast_carcinoma_progesterone_receptor_status
496	xml_metastatic_breast_carcinoma_lab_proc_her2_neu_immunohistochemistry_receptor_status
497	xml_metastatic_breast_carcinoma_progesterone_receptor_level_cell_percent_category
498	xml_metastatic_breast_carcinoma_immunohistochemistry_pr_pos_cell_score
499	xml_metastatic_breast_carcinoma_her2_erbb_pos_finding_cell_percent_category
500	xml_metastatic_breast_carcinoma_erbb2_immunohistochemistry_level_result
501	xml_metastatic_breast_carcinoma_lab_proc_her2_neu_in_situ_hybridization_outcome_type
502	xml_metastatic_breast_carcinoma_her2_neu_chromosone_17_signal_ratio_value
503	xml_her2_neu_breast_carcinoma_copy_analysis_input_total_number
504	xml_breast_carcinoma_immunohistochemistry_progesterone_receptor_pos_finding_scale
505	xml_breast_carcinoma_immunohistochemistry_pos_cell_score
506	xml_country_of_birth
507	xml_country_of_procurement
508	xml_state_province_of_procurement
509	xml_city_of_procurement
510	xml_reflux_history
511	xml_antireflux_treatment_types
512	xml_h_pylori_infection
513	xml_initial_diagnosis_by
514	xml_barretts_esophagus
515	xml_goblet_cells_present
516	xml_history_of_esophageal_cancer
517	xml_number_of_relatives_diagnosed
518	xml_primary_pathology_esophageal_tumor_cental_location
519	xml_primary_pathology_esophageal_tumor_involvement_sites
520	xml_primary_pathology_columnar_metaplasia_present
521	xml_primary_pathology_columnar_mucosa_goblet_cell_present
522	xml_primary_pathology_columnar_mucosa_dysplasia
523	xml_primary_pathology_neoplasm_histologic_grade
524	xml_primary_pathology_initial_pathologic_diagnosis_method
525	xml_primary_pathology_init_pathology_dx_method_other
526	xml_primary_pathology_lymph_node_metastasis_radiographic_evidence
527	xml_primary_pathology_number_of_lymphnodes_positive_by_ihc
528	xml_primary_pathology_planned_surgery_status
529	xml_primary_pathology_treatment_prior_to_surgery
530	xml_primary_pathology_karnofsky_performance_score
531	xml_primary_pathology_eastern_cancer_oncology_group
532	xml_primary_pathology_radiation_therapy
533	xml_primary_pathology_postoperative_rx_tx
534	xml_history_of_disease
535	xml_tests_performed
536	xml_primary_pathology_follicular_percent
537	xml_primary_pathology_lymph_node_involvement_sites
538	xml_primary_pathology_extranodal_involvment_site_other
539	xml_primary_pathology_extranodal_sites_involvement_number
540	xml_primary_pathology_maximum_tumor_dimension
541	xml_primary_pathology_maximum_tumor_bulk_anatomic_site
542	xml_primary_pathology_bone_marrow_biopsy_done
543	xml_primary_pathology_bone_marrow_involvement
544	xml_primary_pathology_bone_marrow_sample_histology
545	xml_presence_of_sarcomatoid_features
546	xml_percent_tumor_sarcomatoid
547	xml_history_pheo_or_para_include_benign
548	xml_history_pheo_or_para_anatomic_site
549	xml_primary_pathology_outside_adrenal
550	xml_primary_pathology_disease_detected_on_screening
551	xml_eye_color
552	xml_primary_pathology_tumor_tissue_site_list
553	xml_primary_pathology_tumor_morphology_list
554	xml_primary_pathology_cytogenetic_abnormality_list
555	xml_primary_pathology_gene_expression_profile_list
556	xml_primary_pathology_extravascular_matrix_patterns
557	xml_primary_pathology_tumor_infiltrating_lymphocytes
558	xml_primary_pathology_tumor_infiltrating_macrophages
559	xml_primary_pathology_tumor_basal_diameter
560	xml_primary_pathology_tumor_basal_diameter_mx
561	xml_primary_pathology_tumor_thickness
562	xml_primary_pathology_tumor_thickness_measurement
563	xml_primary_pathology_extrascleral_extension
564	xml_primary_pathology_extranocular_nodule_size
565	xml_primary_pathology_tumor_shape_pathologic_clinical
566	xml_primary_pathology_metastatic_site_list
567	xml_primary_pathology_other_metastatic_site
568	xml_primary_neoplasm_melanoma_dx
569	xml_sites_of_primary_melanomas
570	xml_breslow_depth_value
571	xml_melanoma_clark_level_value
572	xml_melanoma_ulceration_indicator
573	xml_malignant_neoplasm_mitotic_count_rate
574	xml_days_to_submitted_specimen_dx
575	xml_distant_metastasis_anatomic_site
576	xml_melanoma_origin_skin_anatomic_site
577	xml_prior_systemic_therapy_types
578	xml_interferon_90_day_prior_excision_admin_indicator
579	xml_leukemia_specimen_cell_source_type
580	xml_cumulative_agent_total_dose
581	xml_prior_hematologic_disorder_diagnosis_indicator
582	xml_total_dose_units
583	xml_hydroxyurea_agent_administered_day_count
584	xml_hydroxyurea_administration_prior_registration_clinical_study_indicator
585	xml_atra_exposure
586	xml_steroid_therapy_administered
587	xml_person_history_nonmedical_leukemia_causing_agent_type
588	xml_lab_procedure_blast_cell_outcome_percentage_value
589	xml_leukemia_french_american_british_morphology_code
590	xml_immunophenotype_cytochemistry_testing_results
591	xml_lab_procedure_bone_marrow_cellularity_outcome_percent_value
592	xml_lab_procedure_leukocyte_result_unspecified_value
593	xml_lab_procedure_hemoglobin_result_specified_value
594	xml_lab_procedure_hematocrit_outcome_percent_value
595	xml_platelet_result_count
596	xml_lab_procedure_bone_marrow_blast_cell_outcome_percent_value
597	xml_lab_procedure_bone_marrow_promyelocyte_result_percent_value
598	xml_lab_procedure_bone_marrow_myelocyte_result_percent_value
599	xml_lab_procedure_bone_marrow_metamyelocyte_result_value
600	xml_lab_procedure_bone_marrow_band_cell_result_percent_value
601	xml_lab_procedure_bone_marrow_neutrophil_result_percent_value
602	xml_lab_procedure_bone_marrow_lab_eosinophil_result_percent_value
603	xml_lab_procedure_bone_marrow_basophil_result_percent_value
604	xml_lab_procedure_bone_marrow_lymphocyte_outcome_percent_value
605	xml_lab_procedure_monocyte_result_percent_value
606	xml_lab_procedure_bone_marrow_prolymphocyte_result_percent_value
607	xml_lab_procedure_bone_marrow_promonocyte_count_result_percent_value
608	xml_lab_procedure_abnormal_lymphocyte_result_percent_value
609	xml_cytogenetic_analysis_performed_ind
610	xml_fluorescence_in_situ_hybrid_cytogenetics_metaphase_nucleus_result_count
611	xml_acute_myeloid_leukemia_calgb_cytogenetics_risk_category
612	xml_cytogenetic_abnormalities
613	xml_cytogenetic_abnormality_other
614	xml_fish_evaluation_performed_ind
615	xml_fluorescence_in_situ_hybridization_abnormal_result_indicator
616	xml_fish_test_component_results
617	xml_germline_testing_performed
618	xml_disease_detection_molecular_analysis_method_type
619	xml_molecular_analysis_abnormal_result_indicator
620	xml_molecular_analysis_abnormality_testing_results
621	xml_horm_ther
622	xml_prior_tamoxifen_administered_usage_category
623	xml_hypertension
624	xml_diabetes
625	xml_pregnancies
626	xml_colorectal_cancer
627	xml_primary_pathology_anatomic_neoplasm_subdivision
628	xml_primary_pathology_surgical_approach
629	xml_primary_pathology_peritoneal_wash
630	xml_primary_pathology_pct_tumor_invasion
631	xml_primary_pathology_total_pelv_lnr
632	xml_primary_pathology_pln_pos_light_micro
633	xml_primary_pathology_pln_pos_ihc
634	xml_primary_pathology_total_pelv_lnp
635	xml_primary_pathology_total_aor_lnr
636	xml_primary_pathology_aln_pos_light_micro
637	xml_primary_pathology_aln_pos_ihc
638	xml_primary_pathology_total_aor.lnp
639	xml_diagnosis
640	xml_location_in_lung_parenchyma
641	xml_kras_mutation_result
642	xml_egfr_mutation_performed
643	xml_egfr_mutation_result
644	xml_eml4_alk_translocation_performed
645	xml_eml4_alk_translocation_method
646	xml_pulmonary_function_test_performed
647	xml_pre_bronchodilator_fev1_percent
648	xml_post_bronchodilator_fev1_percent
649	xml_pre_bronchodilator_fev1_fvc_percent
650	xml_post_bronchodilator_fev1_fvc_percent
651	xml_dlco_predictive_percent
652	xml_lymphnode_neck_dissection
653	xml_lymphnode_dissection_method_left
654	xml_lymphnode_dissection_method_right
655	xml_egfr_amplication_status
656	xml_presence_of_pathological_nodal_extracapsular_spread
657	xml_lymphovascular_invasion_present
658	xml_hpv_status_by_p16_testing
659	xml_hpv_status_by_ish_testing
660	xml_patient_personal_medical_history_thyroid_gland_disorder_names
661	xml_patient_personal_medical_history_thyroid_other_specify_text
662	xml_first_degree_relative_history_thyroid_gland_carcinoma_diagnosis_relationship_types
663	xml_person_lifetime_risk_radiation_exposure_indicator
664	xml_primary_thyroid_gland_neoplasm_location_anatomic_site
665	xml_primary_neoplasm_focus_type
666	xml_neoplasm_dimension
667	xml_lymph_node_preoperative_scan_indicator
668	xml_lymph_node_preoperative_assessment_diagnostic_imaging_types
669	xml_extrathyroid_carcinoma_present_extension_status
670	xml_metastatic_neoplasm_confirmed_diagnosis_method_names
671	xml_metastatic_neoplasm_confirmed_diagnosis_method_text
672	xml_metastatic_site
673	xml_other_metastatic_site
674	xml_genotype_analysis_performed_indicator
675	xml_genotyping_results_gene_mutation_not_reported_reasons
676	xml_braf_gene_genotyping_outcome_lab_results_text
677	xml_ras_family_gene_genotyping_outcome_lab_results_text
678	xml_ret_ptc_rearrangement_genotyping_outcome_lab_results_text
679	xml_other_genotyping_outcome_lab_results_text
680	xml_i_131_total_administered_preparation_technique
681	xml_i_131_first_administered_dose
682	xml_i_131_subsequent_administered_dose
683	xml_i_131_total_administered_dose
684	xml_radiation_therapy_administered_preparation_technique_text
685	xml_radiation_therapy_administered_dose_text
686	xml_radiosensitizing_agent_administered_indicator
687	xml_person_occupation_description_text
688	xml_occupation_primary_job
689	xml_chemical_exposure_text
690	xml_person_primary_industry_text
691	xml_diagnosis_subtype
692	xml_disease_extracapsular_extension_ind.3
693	xml_bladder_carcinoma_extracapsular_extension_status
694	xml_metastatic_site_list
695	xml_person_concomitant_prostate_carcinoma_occurrence_indicator
696	xml_person_concomitant_prostate_carcinoma_pathologic_t_stage
697	xml_history_non_muscle_invasive_blca
698	xml_history_ionizing_rt_to_head
699	xml_tumor_location
700	xml_supratentorial_localization
701	xml_seizure_history
702	xml_headache_history
703	xml_mental_status_changes
704	xml_visual_changes
705	xml_sensory_changes
706	xml_motor_movement_changes
707	xml_first_presenting_symptom
708	xml_first_presenting_symptom_longest_duration
709	xml_asthma_history
710	xml_eczema_history
711	xml_hay_fever_history
712	xml_mold_or_dust_allergy_history
713	xml_first_diagnosis_age_asth_ecz_hay_fev_mold_dust
714	xml_food_allergy_history
715	xml_food_allergy_types
716	xml_first_diagnosis_age_of_food_allergy
717	xml_animal_insect_allergy_history
718	xml_animal_insect_allergy_types
719	xml_first_diagnosis_age_of_animal_insect_allergy
720	xml_preoperative_corticosteroids
721	xml_preoperative_antiseizure_meds
722	xml_family_history_of_primary_brain_tumor
723	xml_ldh1_mutation_tested
724	xml_ldh1_mutation_test_method
725	xml_ldh1_mutation_found
726	xml_inherited_genetic_syndrome_found
727	xml_inherited_genetic_syndrome_result
728	xml_history_of_undescended_testis
729	xml_level_of_non_descent
730	xml_undescended_testis_corrected
731	xml_undescended_testis_corrected_age
732	xml_undescended_testis_method_left
733	xml_undescended_testis_method_right
734	xml_history_hypospadias
735	xml_history_fertility
736	xml_family_history_testicular_cancer
737	xml_relation_testicular_cancer_list
738	xml_family_history_other_cancer
739	xml_postoperative_tx_list
740	xml_primary_pathology_bilateral_diagnosis_timing_type
741	xml_primary_pathology_days_to_bilateral_tumor_dx
742	xml_primary_pathology_synchronous_tumor_histology_list
743	xml_primary_pathology_testis_tumor_macroextent
744	xml_primary_pathology_testis_tumor_macroextent_other
745	xml_primary_pathology_testis_tumor_microextent
746	xml_primary_pathology_histology_list
747	xml_primary_pathology_intratubular_germ_cell_neoplasm
748	xml_primary_pathology_lymphovascular_invasion_present
749	xml_primary_pathology_pre_orchi_serum_marker_info
750	xml_primary_pathology_post_orchi_serum_marker_info
751	xml_primary_pathology_post_orchi_lymph_node_dissection
752	xml_primary_pathology_molecular_test_result_list
753	xml_primary_pathology_first_treatment_success
754	xml_surgical_approach
755	xml_peritoneal_wash
756	xml_pct_tumor_invasion
757	xml_total_pelv_lnr
758	xml_pln_pos_light_micro
759	xml_pln_pos_ihc
760	xml_total_pelv_lnp
761	xml_total_aor_lnr
762	xml_aln_pos_light_micro
763	xml_aln_pos_ihc
764	xml_total_aor.lnp
765	xml_relative_family_cancer_history
766	xml_cancer_first_degree_relative
767	xml_history_hepato_carcinoma_risk_factors
768	xml_post_op_ablation_embolization_tx
769	xml_specimen_collection_method_name
770	xml_vascular_tumor_cell_type
771	xml_child_pugh_classification_grade
772	xml_fetoprotein_outcome_value
773	xml_fetoprotein_outcome_lower_limit
774	xml_fetoprotein_outcome_upper_limit
775	xml_platelet_result_lower_limit
776	xml_platelet_result_upper_limit
777	xml_prothrombin_time_result_value
778	xml_inter_norm_ratio_lower_limit
779	xml_intern_norm_ratio_upper_limit
780	xml_albumin_result_specified_value
781	xml_albumin_result_lower_limit
782	xml_albumin_result_upper_limit
783	xml_bilirubin_upper_limit
784	xml_bilirubin_lower_limit
785	xml_total_bilirubin_upper_limit
786	xml_creatinine_value_in_mg_dl
787	xml_creatinine_lower_level
788	xml_creatinine_upper_limit
789	xml_fibrosis_ishak_score
790	xml_adjacent_hepatic_tissue_inflammation_extent_type
791	xml_viral_hepatitis_serologies
792	xml_ablations
793	xml_tumor_residual_disease
794	xml_jewish_origin
795	xml_zone_of_origin
796	xml_tumor_levels
797	xml_days_to_bone_scan_performed
798	xml_bone_scan_results
799	xml_diagnostic_ct_abd_pelvis_performed
800	xml_diagnostic_ct_abd_pelvis_results
801	xml_diagnostic_mri_performed
802	xml_diagnostic_mri_results
803	xml_lymphnodes_examined
804	xml_number_of_lymphnodes_examined
805	xml_biochemical_recurrence
806	xml_days_to_first_biochemical_recurrence
807	xml_primary_pathology_specimen_collection_method_name
808	xml_primary_pathology_history_prior_surgery_type_other
809	xml_primary_pathology_vascular_tumor_cell_type
810	xml_primary_pathology_perineural_invasion_present
811	xml_primary_pathology_child_pugh_classification_grade
812	xml_primary_pathology_ca_19_9_level
813	xml_primary_pathology_ca_19_9_level_lower
814	xml_primary_pathology_ca_19_9_level_upper
815	xml_primary_pathology_fetoprotein_outcome_value
816	xml_primary_pathology_fetoprotein_outcome_lower_limit
817	xml_primary_pathology_fetoprotein_outcome_upper_limit
818	xml_primary_pathology_platelet_result_count
819	xml_primary_pathology_platelet_result_lower_limit
820	xml_primary_pathology_platelet_result_upper_limit
821	xml_primary_pathology_prothrombin_time_result_value
822	xml_primary_pathology_inter_norm_ratio_lower_limit
823	xml_primary_pathology_intern_norm_ratio_upper_limit
824	xml_primary_pathology_albumin_result_specified_value
825	xml_primary_pathology_albumin_result_lower_limit
826	xml_primary_pathology_albumin_result_upper_limit
827	xml_primary_pathology_bilirubin_upper_limit
828	xml_primary_pathology_bilirubin_lower_limit
829	xml_primary_pathology_total_bilirubin_upper_limit
830	xml_primary_pathology_creatinine_value_in_mg_dl
831	xml_primary_pathology_creatinine_lower_level
832	xml_primary_pathology_creatinine_upper_limit
833	xml_primary_pathology_fibrosis_ishak_score
834	xml_primary_pathology_cholangitis_tissue_evidence
835	xml_antireflux_treatment
836	xml_family_history_of_stomach_cancer
837	xml_number_of_relatives_with_stomach_cancer
838	xml_primary_pathology_histological_type_list
839	xml_primary_pathology_history_myasthenia_gravis
840	xml_primary_pathology_section_myasthenia_gravis
841	aligned_reads%.chrm
842	aligned_reads%.chrx
843	aligned_reads%.chry
844	bc_auc.all_reads_all_bases
845	bc_auc.all_reads_annotated_bases
846	bc_auc.unique_reads_all_bases
847	bc_auc.unique_reads_annotated_bases
848	bc_auc.all_%
849	bc_auc.unique_%
850	bc_frag.count
851	bc_frag.kallisto_count
852	bc_frag.kallisto_mean_length
853	bc_frag.mean_length
854	bc_frag.mode_length
855	bc_frag.mode_length_count
856	exon_fc.all_%
857	exon_fc.unique_%
858	exon_fc_count_all.total
859	exon_fc_count_all.assigned
860	exon_fc_count_unique.total
861	exon_fc_count_unique.assigned
862	gene_fc.all_%
863	gene_fc.unique_%
864	gene_fc_count_all.total
865	gene_fc_count_all.assigned
866	gene_fc_count_unique.total
867	gene_fc_count_unique.assigned
868	intron_sum
869	intron_sum_%
870	star.%_of_chimeric_reads
871	star.%_of_reads_mapped_to_multiple_loci
872	star.%_of_reads_mapped_to_too_many_loci
873	star.%_of_reads_unmapped:_other
874	star.%_of_reads_unmapped:_too_many_mismatches
875	star.%_of_reads_unmapped:_too_short
876	star.all_mapped_reads
877	star.average_input_read_length
878	star.average_mapped_length
879	star.deletion_average_length
880	star.deletion_rate_per_base
881	star.insertion_average_length
882	star.insertion_rate_per_base
883	star.mapping_speed,_million_of_reads_per_hour
884	star.mismatch_rate_per_base,_%
885	star.number_of_chimeric_reads
886	star.number_of_input_reads
887	star.number_of_reads_mapped_to_multiple_loci
888	star.number_of_reads_mapped_to_too_many_loci
889	star.number_of_reads_unmapped:_other
890	star.number_of_reads_unmapped:_too_many_mismatches
891	star.number_of_reads_unmapped:_too_short
892	star.number_of_splices:_at/ac
893	star.number_of_splices:_annotated_(sjdb)
894	star.number_of_splices:_gc/ag
895	star.number_of_splices:_gt/ag
896	star.number_of_splices:_non-canonical
897	star.number_of_splices:_total
898	star.uniquely_mapped_reads_%
899	star.uniquely_mapped_reads_number
900	junction_count
901	junction_coverage
902	junction_avg_coverage
903	star.number_of_input_reads_both
904	star.all_mapped_reads_both
905	star.number_of_chimeric_reads_both
906	star.number_of_reads_mapped_to_multiple_loci_both
907	star.number_of_reads_mapped_to_too_many_loci_both
908	star.number_of_reads_unmapped:_other_both
909	star.number_of_reads_unmapped:_too_many_mismatches_both
910	star.number_of_reads_unmapped:_too_short_both
911	star.uniquely_mapped_reads_number_both
912	star.%_mapped_reads_both
913	star.%_chimeric_reads_both
914	star.%_reads_mapped_to_multiple_loci_both
915	star.%_reads_mapped_to_too_many_loci_both
916	star.%_reads_unmapped:_other_both
917	star.%_reads_unmapped:_too_many_mismatches_both
918	star.%_reads_unmapped:_too_short_both
919	star.uniquely_mapped_reads_%_both